Neurobiological substrates for the dark side of compulsivity in addiction
Open accessThe DOI matches its Crossref record; 151 of the 151 references it cites were found in a registry or an index.
Abstract
Drug addiction can be defined by a compulsion to seek and take drug, loss of control in limiting intake, and the emergence of a negative emotional state when access to the drug is prevented. Drug addiction impacts multiple motivational mechanisms and can be conceptualized as a disorder that progresses from impulsivity (positive reinforcement) to compulsivity (negative reinforcement). The construct of negative reinforcement is defined as drug taking that alleviates a negative emotional state. The negative emotional state that drives such negative reinforcement is hypothesized to derive from dysregulation of key neurochemical elements involved in reward and stress within the basal forebrain structures involving the ventral striatum and extended amygdala. Specific neurochemical elements in these structures include not only decreases in reward neurotransmission, such as decreases in dopamine and opioid peptide function in the ventral striatum, but also recruitment of brain stress systems, such as corticotropin-releasing factor (CRF), in the extended amygdala. Acute withdrawal from all major drugs of abuse produces increases in reward thresholds, increases in anxiety-like responses, and increases in extracellular levels of CRF in the central nucleus of the amygdala. CRF receptor antagonists also block excessive drug intake produced by dependence. A brain stress response system is hypothesized to be activated by acute excessive drug intake, to be sensitized during repeated withdrawal, to persist into protracted abstinence, and to contribute to the compulsivity of addiction. Other components of brain stress systems in the extended amygdala that interact with CRF and may contribute to the negative motivational state of withdrawal include norepinephrine, dynorphin, and neuropeptide Y. The combination of loss of reward function and recruitment of brain stress systems provides a powerful neurochemical basis for a negative emotional state that is responsible for the negative reinforcement driving, at least in part, the compulsivity of addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Encyclopedia of Psychology, Vol. 3. · doi:10.1037/10518-009 · Cited by 19,744
LeDoux, J. E. (2000) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.23.1.155 · Cited by 8,444
Paxinos, G. (1985) · Cited by 3,715
Olds, J., & Milner, P. (1954) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0058775 · Cited by 3,176 · cited 1×
“Brain stimulation reward involves widespread neurocircuitry in the brain, but the most sensitive sites defined by the lowest thresholds involve the trajectory of the medial forebrain bundle that connects the ventral tegmental area with the basal forebrain (Olds and Milner, 1954; Koob et al., 1977).”
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Self-citationPsychiatric Aspects of Impulsivity
Moeller, F. G., Barratt, E. S., Dougherty, D. M., Schmitz, J. M., & Swann, A. C. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.11.1783 · Cited by 2,747
Drug abuse: hedonic homeostatic dysregulation
Koob, G. F., & Moal, M. L. (1997) · Science · doi:10.1126/science.278.5335.52 · Cited by 2,535
Self-citationCellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Self-citationDrugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
Self-citationMolecular basis of long-term plasticity underlying addiction
Nestler, E. J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35053570 · Cited by 1,859
Allostasis and Allostatic Load Implications for Neuropsychopharmacology
McEwen, B. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00129-3 · Cited by 1,833
An opponent-process theory of motivation. I. Temporal dynamics of affect
Solomon, R. L., & Corbit, J. D. (1974) · Psychological Review · doi:10.1037/h0036128 · Cited by 1,704 · cited 1×
“Solomon and Corbit (1974) postulated that hedonic, affective, or emotional states, once initiated, are automatically modulated by the central nervous system with mechanisms that reduce the intensity of hedonic feelings.”
Addiction and the brain antireward system
Koob, G. F., & Le Moal, M. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.103006.093548 · Cited by 1,457
Self-citationAllostasis: A New Paradigm to Explain Arousal Pathology
Sterling, P., & Eyer, J. (1988) · Zenodo · doi:10.5281/zenodo.13537700 · Cited by 1,450
Handbook of Life Stress, Cognition and Health
PASTOR, L. H. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1347 · Cited by 1,404
Impulsivity and Inhibitory Control
Logan, G. D., Schachar, R. J., & Tannock, R. (1997) · Psychological Science · doi:10.1111/j.1467-9280.1997.tb00545.x · Cited by 1,394
Is there a common molecular pathway for addiction?
Nestler, E. J. (2005) · Nature Neuroscience · doi:10.1038/nn1578 · Cited by 1,388
Acute effects of cocaine on human brain activity and emotion
Breiter, H. C., Gollub, R. L., Weisskoff, R. M., Kennedy, D. N., Makris, N., Berke, J. D., Goodman, J. M., Kantor, H. L., Gastfriend, D. R., Riorden, J. P., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80374-8 · Cited by 1,270
Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
COMMITMENT, CHOICE AND SELF‐CONTROL1
Rachlin, H., & Green, L. (1972) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1972.17-15 · Cited by 1,204
Transition from Moderate to Excessive Drug Intake: Change in Hedonic Set Point
Ahmed, S. H., & Koob, G. F. (1998) · Science · doi:10.1126/science.282.5387.298 · Cited by 1,154
Self-citationEvidence for Addiction-like Behavior in the Rat
Deroche-Gamonet, V., Belin, D., & Piazza, P. V. (2004) · Science · doi:10.1126/science.1099020 · Cited by 1,135 · cited 1×
“…titrated their cocaine intake, but the LgA rats consistently self-administered almost twice as much cocaine at any dose tested, further suggesting an upward shift in the set point for cocaine reward in the escalated animals (Ahmed and Koob, 1999; Deroche-Gamonet et al., 2004; Mantsch et al., 2004).”
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056 · cited 3×
“A k opioid antagonist blocks the excessive drinking associated with ethanol withdrawal and dependence (Walker and Koob, 2008).”
Self-citationHebb, D. O. (1958) · W.B. Saunders eBooks · doi:10.1037/14200-000 · Cited by 1,009
Plasticity of reward neurocircuitry and the ‘dark side’ of drug addiction
Koob, G. F., & Le Moal, M. (2005) · Nature Neuroscience · doi:10.1038/nn1105-1442 · Cited by 963
Self-citationPsychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854
Neuropsychopharmacology : The Fifth Generation of Progress
Davis, K. L., Charney, D. S., Coyle, J. T., & Nemeroff, C. B. (2002) · Lippincott Williams & Wilkins eBooks · Cited by 747
The amygdala and persistent pain
Neugebauer, V., Li, W., Bird, G. C., & Han, J. S. (2004) · The Neuroscientist · doi:10.1177/1073858403261077 · Cited by 719 · cited 1×
“The extended amygdala has long been hypothesized to have a key role not only in fear conditioning (Le Doux, 2000) but also in the emotional component of pain processing (Neugebauer et al., 2004).”
Dramatic decreases in brain reward function during nicotine withdrawal
Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998) · Nature · doi:10.1038/30001 · Cited by 674
Self-citationCorticotropin-releasing factor, norepinephrine, and stress
Koob, G. F. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00164-x · Cited by 629 · cited 6×
“…titrated their cocaine intake, but the LgA rats consistently self-administered almost twice as much cocaine at any dose tested, further suggesting an upward shift in the set point for cocaine reward in the escalated animals (Ahmed and Koob, 1999; Deroche-Gamonet et al., 2004; Mantsch et al., 2004).”
InfluentialSelf-citationREVIEW: Behavioural assessment of drug reinforcement and addictive features in rodents: an overview
Sanchis‐Segura, C., & Spanagel, R. (2006) · Addiction Biology · doi:10.1111/j.1369-1600.2006.00012.x · Cited by 629
The Dysphoric Component of Stress Is Encoded by Activation of the Dynorphin κ-Opioid System
Land, B. B., Bruchas, M. R., Lemos, J. C., Xu, M., Melief, E. J., & Chavkin, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4458-07.2008 · Cited by 601
Handbook of Life Stress, Cognition and Health
Fisher, S., & REASON, J. T. (1988) · Cited by 575
Pich, E., Lorang, M., Yeganeh, M., Rodriguez de Fonseca, F., Raber, J., Koob, G., & Weiss, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-08-05439.1995 · Cited by 565 · cited 3×
“…major drugs with dependence or abuse potential, with a common response of elevated adrenocorticotropic hormone, corticosterone, and amygdala CRF during acute withdrawal (Rivier et al., 1984; Merlo-Pich et al., 1995; Koob et al., 1994; Rasmussen et al., 2000; Olive et al., 2002; Delfs et al., 2000).”
Self-citationChiara, G. D., & Alan North, R. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90062-b · Cited by 543
Rossetti, Z. L., Hmaidan, Y., & Gessa, G. L. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90706-a · Cited by 521
Impaired inhibitory control of behavior in chronic cocaine users
Fillmore, M. T., & Rush, C. R. (2002) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(01)00206-x · Cited by 519
Vezina, P. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.11.001 · Cited by 515 · cited 1×
“Whether this enhanced drug taking reflects a sensitization of reward or a reward deficit state remains under discussion (Vezina, 2004), but the brain reward and neuropharmacological studies outlined below argue for a reward deficit state driving the increased drug taking during extended access.”
Mucha, R. F., & Herz, A. (1985) · Psychopharmacology · doi:10.1007/bf00432213 · Cited by 510
Postcocaine anhedonia. An animal model of cocaine withdrawal.
Markou, A., & Koob, G. F. (1991) · PubMed · Cited by 505
Self-citationA key role for corticotropin-releasing factor in alcohol dependence
Heilig, M., & Koob, G. F. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.06.006 · Cited by 503 · cited 1×
“Neuropeptide Y (NPY) is a neuropeptide with dramatic anxiolytic-like properties localized to the amygdala and has been hypothesized to have opposite effects to CRF in the negative motivational state of withdrawal from drugs of abuse (Heilig and Koob, 2007).”
Self-citationActivation of Corticotropin-Releasing Factor in the Limbic System During Cannabinoid Withdrawal
Rodrı́guez de Fonseca, F., Carrera, M. R. A., Navarro, M., Koob, G. F., & Weiss, F. (1997) · Science · doi:10.1126/science.276.5321.2050 · Cited by 499 · cited 1×
“However, decreases in activity of the mesolimbic dopamine system and decreases in serotonergic neurotransmission in the nucleus accumbens occur during drug withdrawal in animal studies (Rossetti et al., 1992; Weiss et al., 1992, 1996).”
Self-citationNoradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462
Weiss, F., Parsons, L. H., Schulteis, G., Hyytiä, P., Lorang, M. T., Bloom, F. E., & Koob, G. F. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03474.1996 · Cited by 457
Self-citationCompulsive Drug‐Seeking Behavior and Relapse: Neuroadaptation, Stress, and Conditioning Factors
WEISS, F., CICCOCIOPPO, R., PARSONS, L. H., KATNER, S., LIU, X., ZORRILLA, E. P., VALDEZ, G. R., BEN‐SHAHAR, O., ANGELETTI, S., & RICHTER, R. R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03556.x · Cited by 430
Historical review: molecular and cellular mechanisms of opiate and cocaine addiction
Nestler, E. J. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.005 · Cited by 425
Temporal discounting and preference reversals in choice between delayed outcomes
Green, L., Fristoe, N., & Myerson, J. (1994) · Psychonomic Bulletin & Review · doi:10.3758/bf03213979 · Cited by 417
Rassnick, S., Heinrichs, S. C., Britton, K. T., & Koob, G. F. (1993) · Brain Research · doi:10.1016/0006-8993(93)91352-s · Cited by 407
Self-citationRole of dopamine in drug reinforcement and addiction in humans: results from imaging studies
Volkow, N. D., Fowler, J. S., & Wang, G.-J. (2002) · Behavioural Pharmacology · doi:10.1097/00008877-200209000-00008 · Cited by 398 · cited 1×
“Imaging studies in drug-addicted humans have consistently shown longlasting decreases in the numbers of dopamine D2 receptors in drug abusers compared with controls (Volkow et al., 2002).”
Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence
Walker, B. M., & Koob, G. F. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301438 · Cited by 392 · cited 1×
“A k opioid antagonist blocks the excessive drinking associated with ethanol withdrawal and dependence (Walker and Koob, 2008).”
Self-citationNeurobiological evidence for hedonic allostasis associated with escalating cocaine use
Ahmed, S. H., Kenny, P. J., Koob, G. F., & Markou, A. (2002) · Nature Neuroscience · doi:10.1038/nn872 · Cited by 389 · cited 3×
“thresholds in LgA compared with ShA rats (Ahmed et al., 2002).”
InfluentialSelf-citationValdez, G. R., Roberts, A. J., Chan, K., Davis, H., Brennan, M., Zorrilla, E. P., & Koob, G. F. (2002) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2002.tb02448.x · Cited by 387
Self-citationAmygdala and extended amygdala
Alheid, G. F. (1995) · Medical Entomology and Zoology · Cited by 385
Funk, C. K., O'Dell, L. E., Crawford, E. F., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3096-06.2006 · Cited by 381
Self-citationPersistent Increase in the Motivation to Take Heroin in Rats with a History of Drug Escalation
Ahmed, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00133-5 · Cited by 364
CRF antagonist reverses the “anxiogenic” response to ethanol withdrawal in the rat
Baldwin, H. A., Rassnick, S., Rivier, J., Koob, G. F., & Britton, K. T. (1991) · Psychopharmacology · doi:10.1007/bf02244208 · Cited by 353
Self-citationMartinez, D., Narendran, R., Foltin, R. W., Slifstein, M., Hwang, D.-R., Broft, A., Huang, Y., Cooper, T. B., Fischman, M. W., Kleber, H. D., et al. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.4.622 · Cited by 351
Decreased brain reward produced by ethanol withdrawal
Schulteis, G., Markou, A., Cole, M., & Koob, G. F. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.5880 · Cited by 345
Self-citationEnhanced Alcohol Self‐Administration after Intermittent Versus Continuous Alcohol Vapor Exposure
O'Dell, L. E., Roberts, A. J., Smith, R. T., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000145781.11923.4e · Cited by 342
Self-citationRivier, C., Bruhn, T., & Vale, W. (1984) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21776-1 · Cited by 327
Rimondini, R., Arlinde, C., Sommer, W., & Heilig, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 321
Weiss, F., Markou, A., Lorang, M. T., & Koob, G. F. (1992) · Brain Research · doi:10.1016/0006-8993(92)91327-b · Cited by 318 · cited 1×
“However, decreases in activity of the mesolimbic dopamine system and decreases in serotonergic neurotransmission in the nucleus accumbens occur during drug withdrawal in animal studies (Rossetti et al., 1992; Weiss et al., 1992, 1996).”
Self-citationStinus, L., Le Moal, M., & Koob, G. F. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90106-e · Cited by 317
Self-citationVan Bockstaele, E. J., Colago, E. E. O., & Valentino, R. J. (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00254.x · Cited by 311
Piecing together the Puzzle of Basal Forebrain Anatomy
Heimer, L., & Alheid, G. F. (1991) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4757-0145-6_1 · Cited by 310 · cited 2×
“The neuroanatomical entity termed the extended amygdala (Heimer and Alheid, 1991) may represent a common anatomical substrate integrating brain arousal-stress systems with hedonic processing systems to produce the between-system opponent process elaborated above.”
Long-lasting increase in the set point for cocaine self-administration after escalation in rats
Ahmed, S. H., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130051121 · Cited by 303
Self-citationEuphorigenic drugs: effects on the reward pathways of the brain.
Kornetsky, C. H., & Esposito, R. (1979) · PubMed · Cited by 297
VALENTINO, R. J., FOOTE, S. L., & PAGE, M. E. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb49931.x · Cited by 292
Schulteis, G., Markou, A., Gold, L. H., Stinus, L., & Koob, G. F. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24024-1 · Cited by 285
Self-citationNeuroadaptive mechanisms of addiction: studies on the extended amygdala
Koob, G. F. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.005 · Cited by 278
Self-citationImpulsivity and history of drug dependence
Allen, T. J., Moeller, F. G., Rhoades, H. M., & Cherek, D. R. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00023-4 · Cited by 277
Funk, C. K., Zorrilla, E. P., Lee, M.-J., Rice, K. C., & Koob, G. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.063 · Cited by 276
Self-citationThe Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State
Melis, M., Spiga, S., & Diana, M. (2005) · International Review of Neurobiology · doi:10.1016/s0074-7742(05)63005-x · Cited by 273
Conditioned Withdrawal Drives Heroin Consumption and Decreases Reward Sensitivity
Kenny, P. J., Chen, S. A., Kitamura, O., Markou, A., & Koob, G. F. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0740-06.2006 · Cited by 267
Self-citationSarnyai, Z., Bíró, É., Gardi, J., Vecsernyés, M., Julesz, J., & Telegdy, G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00043-p · Cited by 255 · cited 1×
“Withdrawal from repeated administration of cocaine produces an anxiogenic-like response in the elevated plus maze and defensive burying test, an effect that is reversed by administration of CRF antagonists (Sarnyai et al., 1995; Basso et al., 1999).”
Cannabinoid Transmission and Reward-Related Events
Gardner, E. L., & Vorel, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0219 · Cited by 250
ASTON‐JONES, G., DELFS, J. M., DRUHAN, J., & ZHU, Y. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09284.x · Cited by 250
Valentino, R. J., Page, M. E., & Curtis, A. L. (1991) · Brain Research · doi:10.1016/0006-8993(91)90855-p · Cited by 246
George, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H., O'Dell, L. E., Richardson, H. N., & Koob, G. F. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707585104 · Cited by 245 · cited 8×
“, 2008), nicotine (George et al., 2007), and heroin (Greenwell et al.”
InfluentialSelf-citationOlive, M. F., Koenig, H. N., Nannini, M. A., & Hodge, C. W. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00748-1 · Cited by 237
Heinrichs, S. C., Menzaghi, F., Schulteis, G., Koob, G. F., & Stinus, L. (1995) · Behavioural Pharmacology · doi:10.1097/00008877-199501000-00011 · Cited by 226
Self-citationEscalation of methamphetamine self-administration in rats: a dose–effect function
Kitamura, O., Wee, S., Specio, S. E., Koob, G. F., & Pulvirenti, L. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0353-z · Cited by 217
Self-citationChronic Daily Ethanol and Withdrawal: 1. Long-Term Changes in the Hypothalamo-Pituitary-Adrenal Axis
Rasmussen, D. D., Boldt, B. M., Bryant, C. A., Mitton, D. R., Larsen, S. A., & Wilkinson, C. W. (2000) · Alcoholism: Clinical and Experimental Research · doi:10.1097/00000374-200012000-00013 · Cited by 216
Mantsch, J., Yuferov, V., Mathieu-Kia, A.-M., Ho, A., & Kreek, M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1778-x · Cited by 214
Spangler, R., Unterwald, E. M., & Kreek, M. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90133-a · Cited by 211
Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
Nye, H. E., & Nestler, E. J. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08777-2 · Cited by 211
Richter, R. M., & Weiss, F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990615)32:4%3c254::aid-syn2%3e3.0.co;2-h · Cited by 207
Shaw-Lutchman, T. Z., Barrot, M., Wallace, T., Gilden, L., Zachariou, V., Impey, S., Duman, R. S., Storm, D., & Nestler, E. J. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03663.2002 · Cited by 205
Increased motivation for self-administered cocaine after escalated cocaine intake
Paterson, N. E., & Markou, A. (2003) · NeuroReport · doi:10.1097/00001756-200312020-00019 · Cited by 203
Basso, A. M., Spina, M., Rivier, J., Vale, W., & Koob, G. F. (1999) · Psychopharmacology · doi:10.1007/s002130051028 · Cited by 190
Self-citationValdez, G. R., Zorrilla, E. P., Roberts, A. J., & Koob, G. F. (2003) · Alcohol · doi:10.1016/s0741-8329(03)00020-x · Cited by 186
Self-citationBarr, A. M., & Phillips, A. G. (1999) · Psychopharmacology · doi:10.1007/s002130050812 · Cited by 184
Cocaine self‐administration increases the incentive motivational properties of the drug in rats
Deroche, V., Le Moal, M., & Piazza, P. V. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00696.x · Cited by 180
Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors
Overstreet, D. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.010 · Cited by 172
Nestler, E. J., & Malenka, R. C. (2004) · Scientific American · doi:10.1038/scientificamerican0304-78 · Cited by 170
The basal forebrain : anatomy to function
Napier, T. C., Kalivas, P. W., & Hanin, I. (1991) · Plenum Press eBooks · Cited by 169
α1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol
Walker, B. M., Rasmussen, D. D., Raskind, M. A., & Koob, G. F. (2008) · Alcohol · doi:10.1016/j.alcohol.2007.12.002 · Cited by 167
Self-citationVan Dyke, C., & Byck, R. (1982) · Scientific American · doi:10.1038/scientificamerican0382-128 · Cited by 160
A psychodynamic study of a patient during experimental self-regulated re-addiction to morphine
Wikler, A. (1952) · The Psychiatric Quarterly · doi:10.1007/bf01568465 · Cited by 158
CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats
Specio, S. E., Wee, S., O’Dell, L. E., Boutrel, B., Zorrilla, E. P., & Koob, G. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0983-9 · Cited by 145
Self-citationCorticotropin releasing factor, stress and behavior
Koob, G. F., Heinrichs, S. C., Menzaghi, F., Pich, E. M., & Britton, K. T. (1994) · Seminars in Neuroscience · doi:10.1006/smns.1994.1029 · Cited by 141
Self-citationWee, S., Mandyam, C. D., Lekić, D., & Koob, G. F. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.08.003 · Cited by 140
Self-citationStinus, L., Cador, M., Zorrilla, E. P., & Koob, G. F. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300487 · Cited by 139 · cited 2×
“Systemic administration of a CRF1 receptor antagonist and direct intracerebral administration of a peptide CRF1/CRF2 antagonist also decreased opioid withdrawal-induced place aversions (Stinus et al., 2005; Heinrichs et al., 1995).”
Self-citationLindholm, S., Ploj, K., Franck, J., & Nylander, I. (2000) · Alcohol · doi:10.1016/s0741-8329(00)00118-x · Cited by 136
Changes in brain activation associated with reward processing in smokers and nonsmokers
Martin-Söelch, C., Magyar‐Lehmann, S., Künig, G., Missimer, J. H., Schultz, W., & Leenders, K. L. (2001) · Experimental Brain Research · doi:10.1007/s002210100751 · Cited by 134
A COMPARISON BETWEEN ACUTE AND CHRONIC PHYSICAL DEPENDENCE IN THE CHRONIC SPINAL DOG
Martin, W. R., & Eades, C. G. (1964) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)26938-5 · Cited by 132
Valdez, G. R., Sabino, V., & Koob, G. F. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000128222.29875.40 · Cited by 131
Self-citationSB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats
Knapp, D. J., Overstreet, D. H., Moy, S. S., & Breese, G. R. (2004) · Alcohol · doi:10.1016/j.alcohol.2003.08.007 · Cited by 130
Alonso, G., SZAFARCZYK, A., Balmefrézol, M., & ASSENMACHER, I. (1986) · Brain Research · doi:10.1016/0006-8993(86)90631-1 · Cited by 130
Hernández, G., Hamdani, S., Rajabi, H., Conover, K. L., Stewart, J., Arvanitogiannis, A., & Shizgal, P. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.4.888 · Cited by 127
Breese, G. R., Overstreet, D. H., Knapp, D. J., & Navarro, M. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300706 · Cited by 124
Allostatic view of motivation: implications for psychopathology.
Koob, G. F. (2004) · PubMed · Cited by 124
Self-citationHand, T. H., Koob, G. F., Stinus, L., & Moal, M. L. (1988) · Brain Research · doi:10.1016/0006-8993(88)90452-0 · Cited by 119
Self-citationβ-adrenergic antagonists attenuate withdrawal anxiety in cocaine-and morphine-dependent rats
Harris, G. C., & Aston‐Jones, G. (1993) · Psychopharmacology · doi:10.1007/bf02244345 · Cited by 118
Contarino, A., & Papaleo, F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506999102 · Cited by 118
Paterson, N. E., Myers, C., & Markou, A. (2000) · Psychopharmacology · doi:10.1007/s002130000559 · Cited by 103
Wee, S., Wang, Z., Woolverton, W. L., Pulvirenti, L., & Koob, G. F. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301353 · Cited by 102
Self-citationBiochemical adaptations in the mesolimbic dopamine system in response to heroin self‐administration
Self, D. W., McClenahan, A. W., Beitner‐Johnson, D., Terwilliger, R. Z., & Nestler, E. J. (1995) · Synapse · doi:10.1002/syn.890210405 · Cited by 102
Edwards, G. (1976) · Saxon House , Lexington Books · Cited by 101
Opiate withdrawal-induced place aversion lasts for up to 16 weeks
Stinus, L., Caillé, S., & Koob, G. F. (2000) · Psychopharmacology · doi:10.1007/s002139900358 · Cited by 101
Self-citationChen, S. A., O'Dell, L. E., Hoefer, M. E., Greenwell, T. N., Zorrilla, E. P., & Koob, G. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301008 · Cited by 97 · cited 1×
“Buprenorphine dosedependently decreased heroin self-administration in opioiddependent rats (Chen et al., 2006).”
Self-citationSchulteis, G., Yackey, M., Risbrough, V., & Koob, G. F. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00034-3 · Cited by 97
Self-citationThorsell, A., Repunte-Canonigo, V., O'Dell, L. E., Chen, S. A., King, A. R., Lekic, D., Koob, G. F., & Paolo Sanna, P. (2007) · Brain · doi:10.1093/brain/awm033 · Cited by 91 · cited 2×
“Injection of NPY directly into the central nucleus of the amygdala (Gilpin et al., 2008) and viral vectorenhanced expression of NPY in the central nucleus of the amygdala also blocked the increased drug intake associated with ethanol dependence (Thorsell et al., 2007).”
Self-citationConditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal
Azar, M. R., Jones, B. C., & Schulteis, G. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1514-y · Cited by 91
Thorsell, A., Slawecki, C. J., & Ehlers, C. L. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.01.016 · Cited by 88
Greenwell, T. N., Funk, C. K., Cottone, P., Richardson, H. N., Chen, S. A., Rice, K. C., Zorrilla, E. P., & Koob, G. F. (2009) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00142.x · Cited by 87
Self-citationCaillé, S., Fernández‐Espejo, E., Rénéric, J.-P., Cador, M., Koob, G. F., & Stinus, L. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34977-8 · Cited by 87
Self-citationKenny, P. J., Polis, I. Y., Koob, G. F., & Markou, A. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02443.x · Cited by 80
Self-citationBrain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence
LIU, J., & Schulteis, G. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.06.006 · Cited by 78
Zhang, Z., & Schulteis, G. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.01.013 · Cited by 71
Changes in response to a dopamine receptor antagonist in rats with escalating cocaine intake
Ahmed, S. H., & Koob, G. F. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1682-9 · Cited by 71
Self-citationGreenwell, T. N., Walker, B. M., Cottone, P., Zorrilla, E. P., & Koob, G. F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.07.012 · Cited by 69
Self-citationDopamine Partial Agonist Reverses Amphetamine Withdrawal in Rats
Orsini, C., Koob, G. F., & Pulvirenti, L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00270-6 · Cited by 67
Self-citationMotivational factors in the etiology of drug abuse
Bevins, R. A., Bardo, M. T., & Koob, G. F. (2004) · Cited by 65
Self-citationSlawecki, C. J., Thorsell, A. K., Khoury, A. E., Mathé, A. A., & Ehlers, C. L. (2005) · Neuropeptides · doi:10.1016/j.npep.2005.06.002 · Cited by 64
Rattan, A. K., Koo, K. L., Tejwani, G. A., & Bhargava, H. N. (1992) · Brain Research · doi:10.1016/0006-8993(92)90896-h · Cited by 57
Thorsell, A., Slawecki, C. J., & Ehlers, C. L. (2005) · Alcoholism Clinical and Experimental Research · doi:10.1097/01.alc.0000160084.13148.02 · Cited by 56
Rapid Induction of Conditioned Opiate Withdrawal in the Rat
Baldwin, H. A., & Koob, G. F. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.3 · Cited by 55
Self-citationPulvirenti, L., Balducci, C., Piercy, M., & Koob, G. F. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37716-x · Cited by 52
Self-citationDependence‐Induced Alcohol Drinking by Alcohol‐Preferring (P) Rats and Outbred Wistar Rats
Gilpin, N. W., Richardson, H. N., Lumeng, L., & Koob, G. F. (2008) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00678.x · Cited by 52
Self-citationPulvirenti, L., & Koob, G. F. (1993) · Neuropsychopharmacology · doi:10.1038/npp.1993.23 · Cited by 47
Self-citationIzzo, E., Orsini, C., Koob, G. F., & Pulvirenti, L. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00472-5 · Cited by 45
Self-citationTucci, S., Cheeta, S., Seth, P., & File, S. E. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1403-4 · Cited by 38
Johns, A. R. (1990) · doi:10.1007/978-1-349-20859-3_2 · Cited by 38
Song, Z., & Takemori, A. E. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90458-g · Cited by 33
The effects of buprenorphine on fentanyl withdrawal in rats
Bruijnzeel, A. W., Marcinkiewcz, C. A., Isaac, S. K., Booth, M. M., Dennis, D. M., & Gold, M. S. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0670-2 · Cited by 33
Schulteis, G., Morse, A. C., & Liu, J. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.09.006 · Cited by 31
Effects ofd-amphetamine on concurrent self-stimulation of forebrain and brain stem loci
Koob, G. F., Winger, G. D., Meyerhoff, J. L., & Annau, Z. (1977) · Brain Research · doi:10.1016/0006-8993(77)91015-0 · Cited by 19
Self-citationThe Biological Basis of Cocaine Addiction
Quiñones-Jenab, V. (2001) · Medical Entomology and Zoology · Cited by 17
Cited by
Koob, G. F., & Volkow, N. D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.110 · Cited by 5,340
Self-citationReward Processing by the Opioid System in the Brain
Le Merrer, J., Becker, J. A. J., Befort, K., & Kieffer, B. L. (2009) · Physiological Reviews · doi:10.1152/physrev.00005.2009 · Cited by 1,013
What kinds of things are psychiatric disorders?
Kendler, K. S., Zachar, P., & Craver, C. (2011) · Psychological Medicine · doi:10.1017/s0033291710001844 · Cited by 617
The Development and Maintenance of Drug Addiction
Wise, R. A., & Koob, G. F. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2013.261 · Cited by 559
Self-citationAddiction as a stress surfeit disorder
Koob, G. F., Buck, C. L., Cohen, A., Edwards, S., Park, P. E., Schlosburg, J. E., Schmeichel, B., Vendruscolo, L. F., Wade, C. L., Whitfield, T. W., et al. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.024 · Cited by 483
“…with dependence or abuse potential, with a common response of elevated adrenocorticotropic hormone, corticosterone, and amygdala CRF during acute withdrawal (Rivier et al., 1984; Merlo-Pich et al., 1995; Koob et al., 1994; Rasmussen et al., 2000; Olive et al., 2002; Delfs et al., 2000; Koob, 2009).”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Koob, G. F.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 56
- Pages
- 18-31
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W1977192770
- Cited by
- 458
- References
- 151
- FWCI
- 12.17
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.